Easy being green? Chlorophyll could be used in medical imaging

Photosynthesis isn’t just for plants anymore, researchers say. In a new study published in the journal Advanced Materials, doctors argue that the green pigment in chlorophyll could help physicians peek inside human digestive tracts with certain kinds of imaging procedures.

So far, the method has only been tested on mice, but researchers hypothesize the principle should scale up.

People would drink a special mixture of green nanoparticles called pheophytin. The compound is just chlorophyll with the magnesium removed. Pheophytin reacts with sunlight during photosynthesis, so it could also react with other kinds of light during imaging procedures.

During PET scans, fluorescence imaging and photoacoustic imaging, the pheopytin could help light up digestive tracts and see their inner workings (and potential problems) more clearly. 

Caitlin Wilson,

Senior Writer

As a Senior Writer at TriMed Media Group, Caitlin covers breaking news across several facets of the healthcare industry for all of TriMed's brands.

Around the web

A total of 16 cardiology practices from 12 states settled with the DOJ to resolve allegations they overbilled Medicare for imaging agents used to diagnose cardiovascular disease. 

CCTA is being utilized more and more for the diagnosis and management of suspected coronary artery disease. An international group of specialists shared their perspective on this ongoing trend.

The new technology shows early potential to make a significant impact on imaging workflows and patient care.